The efficacy of ferulic acid in the treatment of dementia

The efficacy of ferulic acid in the treatment of dementia - EFATD

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003683

Enrollment

Registered

2010-05-31

Start date

2010-06-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alzheimer&#39

Interventions

Taking of Ferulic Acid for 6 months followed by Not taking of Ferulic Acid for 6 months. Not taking of Ferulic Acid for 6 months followed by taking of Ferulic Acid for 6 months.

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Due to side effects dementia patients who can not take donepezil.

Exclusion criteria

Exclusion criteria: head trauma,malignancy,metabolic encephalopathy,alcohl abuse, Mental disorder,chronic renal failure and patients treated by major tranquilizer.

Design outcomes

Primary

Measure	Time frame
Hasegawa Dementia Rating Scale, Mini Mental State Examination, Electroencephalography, MRI,NPI(Neuropsychiatric Inventory),NPI-D(Neuropsychiatric Inventory Caregiver Distress Scale),Trail Making Test	—

Countries

Japan

Contacts

Public ContactHiroaki Oguro

Shimane University Hospital Department of Neurology

oguro@med.shimane-u.ac.jp0853202198

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026